Novavax, Inc. (NVAX) Presents at Leerink Global Healthcare Conference 2026 Transcript

Company Strategy Overview - The company has successfully pivoted away from its initial focus on launching a COVID vaccine, which was part of its response to the pandemic [2] - The company has developed significant proof points regarding its technology platform, particularly the Matrix adjuvant technology and nanoparticle technology [2] Innovation and Future Potential - The innovative technologies developed by the company position it well in the vaccine and immunotherapeutic space, indicating potential for future advancements [2]